Skip to main content
. 2016 Aug 30;72(12):1497–1505. doi: 10.1007/s00228-016-2118-x

Table 3.

Demographic characteristics and comorbidity status of the matched hdPS hidden info sub-cohort at baseline

Low dose group n (%) High dose group n (%) Absolute standardized differences
119,376 (100.0) 119,376 (100.0)
Age, mean (SD)a 64.5 (11.2) 64.6 (11.1) 0.012
Male sexb 59,870 (50.2) 60,368 (50.6) 0.008
At least 5 medical outpatient visitsb,d 69,706 (58.4) 67,866 (56.9) 0.031
At least 1 hospitalizationc 28,176 (23.6) 29,679 (24.9) 0.029
Myocardial infarctionc 7427 (6.2) 8605 (7.2) 0.039
Stroke 3515 (2.9) 3961 (3.3) 0.021
Hypertension 49,608 (41.6) 49,833 (41.7) 0.004
Dyslipidemia 38,734 (32.5) 38,328 (32.1) 0.007
Peripheral vascular disease 2248 (1.9) 2742 (2.3) 0.029
Congestive heart failure 4977 (4.2) 5804 (4.9) 0.033
Coronary artery bypass graft 1550 (1.3) 1717 (1.4) 0.012
Percutaneous coronary interventionc 4541 (3.8) 5324 (4.5) 0.033
Dispensation of loop diureticsd 6852 (5.7) 7604 (6.4) 0.026
Dispensation of calcium blockersd 26,961 (22.6) 27,501 (23.0) 0.011
Dispensation of beta-blockersb,d 32,994 (27.6) 37,067 (31.1) 0.075
Dispensation of angiotensin receptor blockersb,d 20,479 (17.2) 21,877 (18.3) 0.031
Dispensation of angiotensin converting enzyme inhibitorsb,d 24,286 (20.3) 26,996 (22.6) 0.055
At least 5 different drugs dispensedd 68,169 (57.1) 69,442 (58.2) 0.022

Comorbidity status, drug dispensations, and medical utilization rates were assessed in the year prior to the cohort entry date. Absolute standardized differences are defined as the between group difference as a proportion of the pooled standard deviation of the two groups

aAt the cohort entry date

bIdentifies baseline characteristics which had 0.10< ASDD ≤0.20 within the unmatched populations [7]

cIdentifies baseline characteristics which had ASDD >0.20 within the unmatched populations [7]

dIdentifies covariates which were hidden to the hdPS algorithm within the hdPS hidden info model